Literature DB >> 1505918

Reversible inhibition of albumin production by rat hepatocytes maintained on a laminin-rich gel (Engelbreth-Holm-Swarm) in response to secretory products of Kupffer cells and cytokines.

P W Kowalski-Saunders1, P J Winwood, M J Arthur, R Wright.   

Abstract

Decreased albumin synthesis by hepatocytes in liver injury is thought to occur in response to Kupffer cell-derived acute-phase cytokines. In this study we used hepatocytes maintained in a differentiated phenotype, by culture on a laminin-rich gel substratum (Engelbreth-Holm-Swarm matrix), to investigate the effects of Kupffer cell-conditioned medium and purified cytokines (interleukin-1, interleukin-6 and tumor necrosis factor-alpha) on albumin synthesis. Kupffer cell-conditioned medium caused a reversible decrease in albumin synthesis to 64.7% of control (p less than 0.01, Wilcoxon's rank sum test, n = 11) on day 2. Repeated doses caused further dose-dependent reversible responses. The same result was obtained when protease inhibitors (alpha 1-antitrypsin and alpha 2-macroglobulin) were added to Kupffer cell-conditioned medium (n = 3), thus eliminating the potential effect of matrix degradation. Pure interleukin-1, interleukin-6 and tumor necrosis factor-alpha also inhibited albumin synthesis (p less than 0.05, Wilcoxon's rank sum test, n = 5), interleukin-6 having the greatest effect. After exposure to interleukin-1 (30 U.ml-1) and tumor necrosis factor-alpha (300 U.ml-1), decreased albumin synthesis was followed by a rebound increase (n = 3). Our results support the hypothesis that reduced albumin synthesis in the acute-phase response is modulated by cytokines released from Kupffer cells. Moreover, our results suggest that hepatocytes may exhibit a compensatory increase in albumin synthesis after cytokine withdrawal. These findings may be of physiological importance in the recovery from injury and the acute-phase response in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505918     DOI: 10.1002/hep.1840160320

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

1.  Versican: a novel modulator of hepatic fibrosis.

Authors:  Terence N Bukong; Sean B Maurice; Barinder Chahal; David F Schaeffer; Paul J Winwood
Journal:  Lab Invest       Date:  2016-01-11       Impact factor: 5.662

2.  Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response.

Authors:  K C Fearon; J S Falconer; C Slater; D C McMillan; J A Ross; T Preston
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

3.  Low serum albumin is an independent risk factor in elderly patients with aggressive B-cell lymphoma: Results from prospective trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.

Authors:  Karin Hohloch; Marita Ziepert; Lorenz Truemper; Christian Buske; Gerhard Held; Viola Poeschel; Bjoern Chapuy; Bettina Altmann
Journal:  EJHaem       Date:  2020-07-13

Review 4.  Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate?

Authors:  Bassel Nazha; Elias Moussaly; Mazen Zaarour; Chanudi Weerasinghe; Basem Azab
Journal:  World J Gastrointest Surg       Date:  2015-12-27

5.  An enrichment model using regular health examination data for early detection of colorectal cancer.

Authors:  Qiang Shi; Zhaoya Gao; Pengze Wu; Fanxiu Heng; Fuming Lei; Yanzhao Wang; Qingkun Gao; Qingmin Zeng; Pengfei Niu; Cheng Li; Jin Gu
Journal:  Chin J Cancer Res       Date:  2019-08       Impact factor: 5.087

6.  Laminin alpha-3 and thrombospondin-1 differently regulate the survival and differentiation of hepatocytes and hepatic stem cells from neonatal mice.

Authors:  Shuai Zhang; Heba E Sharaf Eldin; Wei-Li Gu; Tao-Sheng Li
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 7.  Pretreatment inflammatory markers predicting treatment outcomes in colorectal cancer.

Authors:  Sanghyun An; Hongjin Shim; Kwangmin Kim; Bora Kim; Hui-Jae Bang; Hyejin Do; Hyang-Rae Lee; Youngwan Kim
Journal:  Ann Coloproctol       Date:  2022-03-29

8.  Correlation between the Immune Checkpoint Inhibitors Prognostic Index and Outcomes in Nonsmall Cell Lung Cancer: A Multicentre Analysis.

Authors:  Ying Zhou; Bin Wu; Tian Li; Yong Zhang; Tianqi Xu; Ning Chang; Jian Zhang
Journal:  J Oncol       Date:  2022-08-26       Impact factor: 4.501

9.  The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer.

Authors:  Mengwan Wu; Jing Guo; Lihong Guo; Qiang Zuo
Journal:  Tumour Biol       Date:  2016-06-25

10.  Pretherapeutic Serum Albumin as an Outcome Prognosticator in Head and Neck Adenoid-Cystic Carcinoma.

Authors:  Marlene Friedl; Stefan Stoiber; Faris F Brkic; Lorenz Kadletz-Wanke
Journal:  Biomedicines       Date:  2022-01-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.